Mr. Sollazzo et al., Increased c-myc oncogene expression in Ewing's sarcoma: Correlation with Ki67 proliferation index, TUMORI, 85(3), 1999, pp. 167-173
Aims and background: Ewing's sarcoma is a highly malignant musculoskeletal
tumor composed of small round cells. Although important results have been a
chieved with surgery associated with chemotherapy, recurrent disease is sti
ll a major problem, In order to define new prognostic factors useful for th
erapeutic decision-making, we conducted a study on 38 Ewing's sarcoma sampl
es in which c-myc oncogene expression and Ki67 proliferation index were cor
related with clinical outcome.
Methods and study design: Nineteen patients developed metastases during fol
low-up and 10 of these patients died. C-myc and Ki67 protein expression was
evaluated by immunohistochemistry performed on 5 mu m formalin-fixed and p
araffin-embedded sections, while the c-myc mRNA transcript was localized us
ing in situ hybridization.
Results: A statistically positive correlation was found between c-myc prote
in and Ki67 (P=0.001) and c-myc mRNA and Ki67 expression (P=0.047), The 38
patients were divided into two groups using as the cutoff 50% of Ki67-posit
ive cells. The disease-free survival and overall survival estimates were 68
% and 90%, respectively, in the group of patients with a percentage of Ki67
-positive cells <50%, and 25% and 50%, respectively, in the group with a pe
rcentage of Ki67-positive cells greater than or equal to 50%. The differenc
e between the survival curves was statistically significant (P<0.05 and P<0
.01), Furthermore, relapsed patients had a high and uniform expression of c
-myc protein and mRNA compared to disease-free patients.
Conclusion: These results suggest a possible role of the c-myc oncogene and
Ki67 antigen in the malignant progression of Ewing's sarcoma.